BioMarin Pharmaceutical Inc.

NasdaqGS:BMRN Stock Report

Market Cap: US$15.6b

BioMarin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:BMRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Mar 24SellUS$172,223Jean-Jacques BienaimeIndividual2,000US$86.71
05 Mar 24SellUS$3,010,396Henry FuchsIndividual35,341US$85.18
27 Feb 24SellUS$90,350Jean-Jacques BienaimeIndividual1,000US$90.35
10 Aug 23SellUS$1,085,111Henry FuchsIndividual12,000US$90.43
09 Aug 23SellUS$500,109C. GuyerIndividual5,360US$93.30
08 Aug 23SellUS$983,662George DavisIndividual11,000US$89.42
08 Aug 23SellUS$882,140Jean-Jacques BienaimeIndividual10,000US$88.29

Insider Trading Volume

Insider Buying: BMRN insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of BMRN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,4980.00183%
State or Government104,0830.0543%
Individual Insiders1,349,6000.704%
Institutions190,159,69999.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 71.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.7%
PRIMECAP Management Company
18,414,374US$1.5b0.04%1.26%
9.51%
The Vanguard Group, Inc.
18,050,062US$1.5b1.97%0.03%
7.74%
BlackRock, Inc.
14,681,644US$1.2b0.51%0.02%
7.37%
Dodge & Cox
13,994,063US$1.1b-1.13%0.58%
5.68%
Capital Research and Management Company
10,774,641US$885.4m79%0.05%
3.55%
State Street Global Advisors, Inc.
6,730,515US$553.1m4.21%0.03%
2.86%
Columbia Management Investment Advisers, LLC
5,419,366US$445.3m4.95%0.12%
2.72%
Barclays PLC Private Banking & Investment Banking Investment
5,159,429US$424.0m5.3%0.33%
2.58%
Viking Global Investors LP
4,889,454US$401.8m16%1.62%
2.27%
Avoro Capital Advisors LLC
4,300,000US$353.3m11.7%5.76%
1.78%
Deutsche Asset & Wealth Management
3,384,512US$278.1m145%0.16%
1.77%
Norges Bank Investment Management
3,361,310US$276.2m22.1%0.03%
1.58%
Elliott Management Corporation
3,000,338US$246.5m0%2.25%
1.51%
Geode Capital Management, LLC
2,872,432US$236.0m3.98%0.02%
1.47%
Janus Henderson Group plc
2,790,343US$229.3m-18.5%0.11%
1.34%
BNY Mellon Asset Management
2,541,990US$208.9m6.94%0.04%
1.12%
Nomura Holdings Inc, Securities & Investment Arm
2,132,937US$175.3m-24.9%0.9%
1.09%
JP Morgan Asset Management
2,071,088US$170.2m-9.27%0.02%
0.97%
Parnassus Investments, LLC
1,849,348US$152.0m-20.9%0.36%
0.85%
T. Rowe Price Group, Inc.
1,605,983US$132.0m33.3%0.01%
0.83%
OrbiMed Advisors LLC
1,571,410US$129.1m-2.71%2.09%
0.82%
Managed Account Advisors LLC
1,563,081US$128.4m-0.08%0.03%
0.79%
Palo Alto Investors LP
1,500,749US$123.3m-18%15.05%
0.76%
Pictet Asset Management Limited
1,436,723US$118.1m-26%0.09%
0.73%
Legal & General Investment Management Limited
1,390,526US$114.3m14.3%0.03%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.